Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey

• Main Authors: J. P. Sevilla (Author), Andrew Stawasz (Author), Daria Burnes (Author), Anubhav Agarwal (Author), Basak Hacibedel (Author), Kerem Helvacioglu (Author), Reiko Sato (Author), David E. Bloom (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Productivity benefits of health technologies are ignored in typical economic evaluations from a health payer's perspective, risking undervaluation. We conduct a productivity-based cost-benefit analysis from a societal perspective and estimate indirect costs of adult pneumococcal disease, vaccin...